Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Hoth Therapeutics, Inc. (HOTH) had Return on Tangible Equity of -43.70% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.69M |
|
-- |
|
-- |
|
$2.60M |
|
$-2.60M |
|
$-0.08M |
|
$-2.69M |
|
$-2.60M |
|
$-2.69M |
|
$-2.69M |
|
$-2.69M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
13.81M |
|
13.81M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$6.86M |
|
-- |
|
$0.74M |
|
$7.60M |
|
$1.45M |
|
-- |
|
-- |
|
$1.45M |
|
$6.15M |
|
$6.15M |
|
$6.15M |
|
15.51M |
|
| Cash Flow Statement Financials | |
$-9.80M |
|
$-0.30M |
|
$9.31M |
|
$7.04M |
|
$6.25M |
|
$-0.79M |
|
$1.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.70% |
|
|
Return on Tangible Equity |
-43.70% |
-35.35% |
|
-43.70% |
|
$0.40 |
|
$-0.71 |
|
$-0.71 |
|